fludarabine has been researched along with Hematochezia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amarasinghe, K; Dalley, C; Dokal, I; Gupta, V; Laurie, A; Marsh, J | 1 |
1 other study(ies) available for fludarabine and Hematochezia
Article | Year |
---|---|
Late death after unrelated-BMT for dyskeratosis congenita following conditioning with alemtuzumab, fludarabine and melphalan.
Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Bone Marrow Transplantation; Child; Dyskeratosis Congenita; Fatal Outcome; Gastrointestinal Hemorrhage; Humans; Male; Transplantation Conditioning; Vidarabine | 2007 |